NEUROCRINE BIOSCIENCES INC·4

Jun 15, 5:31 PM ET

Grigoriadis Dimitri E. 4

4 · NEUROCRINE BIOSCIENCES INC · Filed Jun 15, 2020

Insider Transaction Report

Form 4
Period: 2020-06-11
Grigoriadis Dimitri E.
Vice President, Research
Transactions
  • Exercise/Conversion

    Common Stock

    2020-06-11$32.99/sh+2,710$89,40374,702 total
  • Exercise/Conversion

    Common Stock

    2020-06-11$43.24/sh+1,049$45,35977,563 total
  • Exercise/Conversion

    Incentive Stock Option

    2020-06-11$35.99/sh1,812$65,2140 total
    Exercise: $35.99Exp: 2026-02-05Common Stock (1,812 underlying)
  • Exercise/Conversion

    Incentive Stock Option

    2020-06-11$32.99/sh2,710$89,4030 total
    Exercise: $32.99Exp: 2025-02-03Common Stock (2,710 underlying)
  • Exercise/Conversion

    Common Stock

    2020-06-11$35.99/sh+1,812$65,21476,514 total
  • Exercise/Conversion

    Incentive Stock Option

    2020-06-11$43.24/sh1,049$45,3592,151 total
    Exercise: $43.24Exp: 2027-02-06Common Stock (1,049 underlying)
Footnotes (3)
  • [F1]Option granted February 3, 2015 and vested monthly over four years.
  • [F2]Option granted February 5, 2016 and vested monthly over four years.
  • [F3]Option granted February 6, 2017 and vests monthly over four years.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION